Description

8H,10H-7A,12A-(Iminomethano)Indolizino[6,7-H]Pyrano[3,2-A]Carbazole-8,16-Dione, 3,11,12,13,13A,14-Hexahydro-3,3,14,14-Tetramethyl-, 15-Oxide, (7As,12As,13As)- is a complex, high-purity heterocyclic compound serving as a critical advanced pharmaceutical intermediate and a versatile scaffold for organic synthesis. Its intricate fused-ring structure makes it a valuable building block for developing novel active pharmaceutical ingredients (APIs) and specialty fine chemicals. This compound is primarily utilized by research institutions and manufacturers in the pharmaceutical, agrochemical, and material science sectors for its unique chemical properties.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of complex drug candidates, particularly for central nervous system (CNS) and anti-cancer therapeutics.
• Organic Synthesis Building Block: Serves as a sophisticated scaffold for constructing novel heterocyclic compounds in medicinal chemistry research.
• Agrochemical Research: Used in the development of new-generation pesticides and herbicides due to its bioactive core structure.
• Material Science: Investigated as a potential monomer or dopant for creating advanced organic electronic materials and dyes.
• Academic & R&D: Essential for chemical research in universities and corporate labs focusing on synthetic methodology and new molecular entities.
• Fine Chemical Production: Employed in the custom synthesis of high-value, low-volume specialty chemicals for various industrial applications.

Basic Information

Product Name	8H,10H-7A,12A-(Iminomethano)Indolizino[6,7-H]Pyrano[3,2-A]Carbazole-8,16-Dione, 3,11,12,13,13A,14-Hexahydro-3,3,14,14-Tetramethyl-, 15-Oxide, (7As,12As,13As)-
CAS No.	269741-97-1
Molecular Formula	C27H28N2O4
Molecular Weight	444.53 g/mol
Synonyms	(7aS,12aS,13aS)-3,11,12,13,13a,14-Hexahydro-3,3,14,14-tetramethyl-8H,10H-7a,12a-(iminomethano)indolizino[6,7-h]pyrano[3,2-a]carbazole-8,16-dione 15-oxide; 269741-97-1; Complex Indolizino-Pyrano-Carbazole Derivative; IPC Intermediate; Fused Heterocyclic Carbazole N-Oxide.
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided with each shipment. We support development and commercial projects with quality standards suitable for GMP-grade pharmaceutical synthesis upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and light-sensitive; containers must be kept tightly sealed and under an inert atmosphere (e.g., nitrogen or argon) for long-term storage to prevent degradation.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single unknown impurity ≤ 0.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.